Applying recent advances in the science of CFTR-based therapeutics to improve outcomes in patients with cystic fibrosis

JP P. Clancy*, Debbie S. Benitez, Isabelle Fajac, Manu Jain, Steven M. Rowe, Gregory Sawicki

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

The content for this activity is based on the satellite symposium, "Applying Recent Advances in the Science of CFTR-based Therapeutics to Improve Outcomes in Patients With Cystic Fibrosis", that was presented at the 30th Annual North American Cystic Fibrosis Conference in Orlando, Florida on October 28, 2016 (Online access: http://courses.elseviercme.com/nacfc16/655e). The content highlights the latest advancements, particularly in CFTR-based therapeutics, for the treatment of patients with cystic fibrosis. Expert faculty discuss the most up-to-date analysis for clinical decision-making, including updates on assessment, monitoring, and management of patients treated with CFTR modulator therapies. The goal of this activity is to increase the knowledge and competencies of the multidisciplinary team involved in the management of patients with CF, and provide strategies for improving the lives of patients. Upon completion of this activity, healthcare providers will be better equipped with imperative information for creating more effective personalized treatment plans and improving patient outcomes.

Original languageEnglish (US)
JournalJournal of Cystic Fibrosis
DOIs
StateAccepted/In press - 2017

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Applying recent advances in the science of CFTR-based therapeutics to improve outcomes in patients with cystic fibrosis'. Together they form a unique fingerprint.

Cite this